Minutia CEO Catherine "Katy" Digovich and Leadership Team members Sapna Puri and Janna Register spent the week moving and shaking at @JPM 2025! Extra thanks to the fine folks at UCSF Innovation Ventures for the invitation to present at their Innovation Showcase and Reception! Darya Bubman Catherine Smith Todd Pazdera #T1D #celltherapy #biotech #startup
关于我们
We are working towards a transplant of insulin producing cells combined with nanosensors for diabetes that is so safe and effective we would put it in our own bodies and the bodies of people we love. We believe our ability to create more robust and controlled insulin producing cell transplants that can be monitored in vivo over time will revolutionize the current clinical landscape for diabetes and cell replacement therapy.
- 网站
-
https://minutia.co
Minutia 的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Oakland，CA
- 类型
- 私人持股
- 创立
- 2021
- 领域
- diabetes、insulin、cell therapy、nanosensors、gold nanoparticles和transplant
地点
-
主要
获取路线
US，CA，Oakland，94610
Minutia 员工
动态
-
Join the Minutia team THIS EVENING at the UCSF Innovation Ventures Showcase and Reception at J.P. Morgan. CEO Catherine "Katy" Digovich will present highlights of our exciting progress toward a cure for #T1D. This exciting event highlights UCSF’s groundbreaking innovations in health and life sciences while fostering meaningful connections across sectors. Whether you’re in health care, research, or investment, this is a can’t-miss opportunity. PRE-REGISTRATION REQUIRED https://lnkd.in/ghVP-NPs
-
Minutia is honored to announce Daniel Bradbury as our new Board Chairman! Dan?brings an incredibly impressive set of skills and experiences to this role:?he's the Managing Member of BioBrit, LLC, a Life Sciences Consulting and Investment Firm, and the Executive Chairman, Co-Founder and former CEO of Equillium, Inc., a publicly traded biopharmaceutical company focused on developing products to treat severe autoimmune and inflammatory disorders. He is also the former President, Chief Executive Officer, and Director of Amylin Pharmaceuticals, a biopharmaceutical company focused on metabolic diseases.?Minutia will benefit *tremendously* from Dan's?40 years of experience creating and implementing strategies to bring novel medicines to market, and we could not be more grateful for his commitment to our work! #diabetes #T1D #celltherapy #biopharmaceutical #startup Catherine "Katy" Digovich William (Bill) Hyun Peter Barrett
-
Exciting and important event at The Australian Centre for Accelerating Diabetes Innovations (ACADI) last week! We at Minutia are honored to have gotten a mention in their proceedings, for our work to #cure #T1D. We're thrilled to be in conversation with this impactful organization! Elpis Barons Catherine "Katy" Digovich Peter Barrett #celltherapy #diabetes #type1diabetes
Key themes this afternoon at the The Australian Centre for Accelerating Diabetes Innovations (ACADI) Partnering Summit 2024 in #Melbourne on #WorldDiabetesDay were #collaboration and #thefuture. ?????????? ‘The Power of Collaboration’ panel session provided insight on driving #innovation and #improving #patient #outcomes through #collaboration. The Australian Centre for Accelerating Diabetes Innovations (ACADI) has six #platforms for its #researchers to help facilitate and increase collaboration all around Australia. Everyone on the panel uses and is interested in #multidisciplinary #approaches to diabetes research to #optimise outcomes. ????? ‘The Future of Diabetes Innovations’ panel session explored the most promising innovations in diabetes care and what lies ahead for research, industry and community engagement. Members of the panel answered a range of questions from participants on topics including community insights and needs, the importance of involving people who live with diabetes in research and innovation, and the future of managing diabetes personally via innovative tech. ????????????????????? Bringing together the Diabetes community from around Australia and including international speakers, the ACADI Partnering Summit is a valuable event for clinicians, researchers, people who live with diabetes and others who work in this space to come together to learn from each other, collaborate and look to the future. ??????? From insightful panel presentations and info-packed talks to a personal experience of living with Diabetes from a First Nations participant, Bernard Kelly-Edwards, at the end of proceedings before the final networking session, the Partnering Summit has added value, informed, educated, facilitated yet more collaboration and inspired the community and everyone here today. ?? ? Hon. Jaala Pulford | Stuart Dignam | Lisa Dubé | Lauren Eve Kelly | Erin McAllum | Mana Liao, PhD | Amelia Vom | Kevin Pfleger | Tracey Wilkinson Rebekah Hinton | Diabetes Australia | Baker Heart and Diabetes Institute | World Diabetes Day | Diabetes Victoria | Sandra Scalzo | Belinda Kelly |
-
-
-
-
-
+5
-
-
Enjoy the live-stream of Minutia's recent panel discussion, hosted by UCSF Innovation Ventures! No login required: https://lnkd.in/gnJm8zqM
-
Yesterday's panel discussion, hosted by UCSF Innovation Ventures, was a fabulous event! Watch the live-stream! https://lnkd.in/gnJm8zqM. Minutia CEO Catherine "Katy" Digovich shared priceless advice for women CEOs navigating a the male-dominated world or venture capital, VP of cell therapy, Sapna Puri, discussed the experience of moving from academia to industry, and co-founder Matthias Hebrok shared his experience as a world-renoun scientist starting a company that promises to do great things. *Tremendous* thanks to our VC teammates, Pae Wu of SOSV and Sarah Lucas of Lucas Venture Group for bringing their wisdom and perspective to this rich conversation, about supporting women-led startups. Todd Pazdera Darya Bubman Mohan Iyer William (Bill) Hyun Bakar Labs Peter Barrett
-
-
-
-
-
+1
-
-
Please join the Minutia team TOMORROW, 4pm at University of California, San Francisco Genentech Hall for a panel discussion about the experience of working to move academic research into a start-up environment, and specifically what that can be like?for a predominantly female team. This event is a collaboration with UCSF Innovation Ventures, and will include comments from Minutia co-founder and former Director of the UCSF Diabetes Center, Matthias Hebrok, and VCs Sarah Lucas, of Lucas Venture Group, and Pae Wu, of SOSV/IndieBio. Details below! https://lnkd.in/gi9tFPDM #diabetes #T1D #Typeone Catherine "Katy" Digovich
-
Minutia is excited to host a lab tour for attendees of the Breakthrough T1D Mission Summit, happening in San Francisco October 19-21! We plan to show this savvy group of donors our novel concept for a functional cure for type 1 diabetes, and the impressive progress we've made so far, with great support from Breakthrough T1D. https://lnkd.in/gEYTXS4m Bakar Labs Catherine "Katy" Digovich #celltherapy #bioengineering Lauren O'Neill WILL HALL #diabetes #t1d #type1diabetes #diabetescures #startup #biotech
-
On October 23rd join Minutia's Catherine "Katy" Digovich, Matthias Hebrok and Sapna Puri, Pae Wu of SOSV and Sarah Lucas of Lucas Venture Group for an in-person panel?discussion hosted by UCSF Innovation Ventures. Main topics: moving academic research into a start-up environment, and how the process can be different?for a predominantly female team. This promises to be an engaging and educational event! https://lnkd.in/gi9tFPDM Peter Barrett Mohan Iyer William (Bill) Hyun #diabetes #T1D #startup #celltherapy Women In Bio - Engage. Educate. Empower.
-
The Minutia team is excited and humbled to receive another grant from The National Institutes of Health! The award of this Phase I SBIR grant will help advance Minutia’s mission to create a functional cure for Type 1 diabetes by supporting our work to create insulin-producing islets that are resistant to autoimmune attack, and nanosensor technology to measure the intracellular response to inflammation. Please read and share the press release, below! And, as *always*, tremendous thanks to our fans, friends and supporters! #biotech #diabetes #T1D #startup #nanotechnology #celltherapy #type1diabetes Peter Barrett Bakar Labs Catherine "Katy" Digovich Lucas Venture Group